More than a dozen men who claim to have suffered serious personal injury after taking the prescription testosterone product AndroGel, have requested that lawsuits filed against the manufacturer, Abbott Laboratories, Inc. and AbbVie Inc., be consolidated before U.S. District Court Judge Matthew F. Kennelly. The creation of a Multidistrict Litigation, or MDL, will allow the court to consolidate pre-trial resources and allow for a more efficient litigation process for both parties. (In Re: AndroGel Product Liability Litigation, MDL Docket No. Pending 36, JPML)
Plaintiffs in these lawsuits allege that they have suffered serious injuries after they were prescribed and took prescription testosterone drugs. Injuries include heart attacks, strokes, and death. Hundreds of injured men claim that the drug manufacturer failed to warn doctors and patients of an increased risk for serious cardiovascular injuries associated with these prescription drugs.
Concern for patient safety related to testosterone replacement therapy has been increasing over the past year. One study in the Journal of the American Medical Association indicated that some men using testosterone replacement drugs demonstrated a 30% increased risk for heart attack and stroke.
The FDA announced earlier this year that it was launching its own investigation into the safety of testosterone replacement therapy drugs for an increased risk of blood clots, heart attacks, strokes, and death.
Men who have taken prescription testosterone drugs and have suffered a serious personal injury should contact an experienced product liability lawyer to learn about their legal rights. Our firm has talked to thousands of people who have suffered serious personal injury as a result of a drug or medical device manufacturer’s negligence and can provide you with a free case evaluation.